These findings support strategies for targeting TGF-β in PDAC [13], [14], [35], and are consistent with the observation that there is a strong EGFR in situ hybridization signal in the tumor vasculature in PDAC in humans [36] and with proposed roles of EGFR in tumor angiogenesis. This evidence concerns the gene EGFR and neoplasm.